Skip to main content

Advertisement

SpringerLink
Log in

Teriparatide’s role in the management of bisphosphonate-associated osteonecrosis of the jaw

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kwon YD, Lee DW, Choi BJ, Lee JW, Kim DY (2012) Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int. doi:10.1007/s00198-011-1882-9

  2. Subramanian G, Cohen HV, Quek SY (2011) A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide’s potential role in its resolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(6):744–753

    Article  PubMed  Google Scholar 

  3. Schubert M, Klatte I, Linek W, et al. (2011) The Saxon Bisphosphonate Register—therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. Oral Oncol. doi:10.1016/j.oraloncology.2011.11.004

  4. Stanton DC, Balasanian E (2009) Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Maxillofac Surg 67(5):943–950

    Article  PubMed  Google Scholar 

  5. Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363(25):2473–2474

    Article  PubMed  CAS  Google Scholar 

  6. Lee JJ, Cheng SJ, Jeng JH et al (2010) Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck. doi:10.1002/hed.21380

  7. Harper RP, Fung E (2007) Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1–34)]. J Oral Maxillofac Surg 65(3):573–580

    Article  PubMed  Google Scholar 

  8. Tsai KY, Huang CS, Huang GM, Yu CT (2010) More on the resolution of bisphosphonate-associated osteonecrosis of the jaw. J Rheumatol 37(3):675, author reply 76

    Article  PubMed  Google Scholar 

  9. Bashutski JD, Eber RM, Kinney JS et al (2010) Teriparatide and osseous regeneration in the oral cavity. N Engl J Med 363(25):2396–2405

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Diagnostic Sciences, UMDNJ—New Jersey Dental School, 110 Bergen Street, Newark, NJ, 07103, USA

    G. Subramanian & S. Y. P. Quek

Authors
  1. G. Subramanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Y. P. Quek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Y. P. Quek.

Additional information

An author's reply to this comment is available at doi:10.1007/s00198-012-1961-6.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Subramanian, G., Quek, S.Y.P. Teriparatide’s role in the management of bisphosphonate-associated osteonecrosis of the jaw. Osteoporos Int 23, 2727–2728 (2012). https://doi.org/10.1007/s00198-012-1951-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-012-1951-8

Keywords

Search

Navigation